(NUSI) NEOS Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US26922A1723
NUSI: Stocks, Options
The NEOS ETF Trust (NYSE ARCA:NUSI) is an actively-managed exchange-traded fund that employs a unique investment strategy to achieve its objective. By combining a portfolio of stocks from the Nasdaq-100 Index with a put spread options collar on the same index, the fund aims to balance potential upside with downside protection.
The funds investment approach is centered around maintaining at least 80% of its net assets, plus any borrowings for investment purposes, in securities or derivative instruments linked to the Nasdaq-100 Index. This indicates a strong correlation with the performance of the index, while the put spread options collar is likely used to mitigate potential losses. As a non-diversified fund, NUSI may exhibit higher volatility compared to its diversified counterparts.
Analyzing the available data, we can infer that NUSI has demonstrated significant growth, with its Assets Under Management (AUM) standing at $298.17 million. This suggests a level of investor confidence in the funds strategy.
From a technical standpoint, NUSIs recent price action indicates a bullish trend, with the last price of $49.86 exceeding both its 20-day Simple Moving Average (SMA20) of $48.41 and its 50-day Simple Moving Average (SMA50) of $48.96. The stock is also significantly above its 200-day Simple Moving Average (SMA200) of $32.03, further reinforcing the bullish sentiment. The Average True Range (ATR) of 1.12, representing a 2.25% daily volatility, suggests moderate price fluctuations.
Given the current technical and fundamental data, a forecast for NUSI can be constructed. With the Nasdaq-100 Index continuing to be a dominant force in the tech-heavy equity market, NUSIs correlation to this index is likely to drive its performance. Assuming the index maintains its current momentum and the funds put spread options collar effectively manages downside risk, NUSI may continue its upward trajectory. A potential target could be the 52-week high of $53.72, representing a 7.7% increase from the current price. However, its crucial to monitor the funds AUM, trading volumes, and overall market conditions to adjust this forecast accordingly.
Additional Sources for NUSI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
NUSI ETF Overview
Market Cap in USD | 310m |
Category | Equity Hedged |
TER | 0.68% |
IPO / Inception | 2019-12-19 |
NUSI ETF Ratings
Growth Rating | 76.1 |
Fundamental | - |
Dividend Rating | 63.8 |
Rel. Strength | 94.1 |
Analysts | - |
Fair Price Momentum | 59.97 USD |
Fair Price DCF | - |
NUSI Dividends
Dividend Yield 12m | 10.92% |
Yield on Cost 5y | 22.30% |
Annual Growth 5y | -0.95% |
Payout Consistency | 80.7% |
Payout Ratio | % |
NUSI Growth Ratios
Growth Correlation 3m | 78% |
Growth Correlation 12m | 94% |
Growth Correlation 5y | 44.8% |
CAGR 5y | 22.18% |
CAGR/Max DD 5y | 0.71 |
Sharpe Ratio 12m | 0.15 |
Alpha | 108.76 |
Beta | 0.186 |
Volatility | 10.05% |
Current Volume | 16.1k |
Average Volume 20d | 18.4k |
As of June 19, 2025, the stock is trading at USD 51.75 with a total of 16,051 shares traded.
Over the past week, the price has changed by -0.10%, over one month by +1.45%, over three months by +4.65% and over the past year by +114.10%.
Yes. Based on ValueRay´s Analyses, NEOS Trust (NYSE ARCA:NUSI) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.10 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NUSI is around 59.97 USD . This means that NUSI is currently undervalued and has a potential upside of +15.88% (Margin of Safety).
NEOS Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, NUSI NEOS Trust will be worth about 64.9 in June 2026. The stock is currently trading at 51.75. This means that the stock has a potential upside of +25.43%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 64.9 | 25.4% |